We found that while oBHV alone is sufficient to induce bona fide ICD and induce the activation of circulating CD8+ T cells and tumor-infiltrating lymphocytes (TILs), low-dose mitomycin (MMC) chemotherapy is required to enable ICI to significantly extend survival. The gene discussed is CD8A; the disease is neoplasm.